Document is current
Any future updates will be listed below
-
Authors
Nakajima, Waki
Hatano, Mai
Ohtani, Yohei
Tani, Hideaki
Yatomi, Taisuke
Tsuchimoto, Shohei
Fujimoto, Yu https://orcid.org/0009-0004-0664-9529
Eiro, Tsuyoshi
Ichijo, Sadamitsu
Nakano, Kotaro
Arisawa, Tetsu https://orcid.org/0000-0001-7694-8728
Takada, Yuuki
Kimura, Kimito
Abe, Hiroki
Sano, Akane
Nomoto-Takahashi, Kie
Yonezawa, Kengo
Tomiyama, Sota
Nagai, Nobuhiro
Kusudo, Keisuke
Honda, Shiori
Moriyama, Sotaro
Nakajima, Shinichiro https://orcid.org/0000-0002-2601-2195
Yamada, Takashige https://orcid.org/0000-0002-1152-9853
Iwabuchi, Yu
Jinzaki, Masahiro
Yoshimura, Kimio
Syed, Shariful A.
Tsugawa, Sakiko https://orcid.org/0000-0001-9974-316X
Uchida, Hiroyuki https://orcid.org/0000-0002-0628-7036
Takahashi, Takuya https://orcid.org/0000-0001-6523-0622
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP16dm0107124)
Japan Agency for Medical Research and Development (JP19dm0207072)
Japan Agency for Medical Research and Development (JP24wm0625304)
Japan Agency for Medical Research and Development (JP14dm0207023)
Japan Agency for Medical Research and Development (JP25gm7010019)
MEXT | Japan Society for the Promotion of Science (22H03001)
MEXT | Japan Society for the Promotion of Science (20H00549)
MEXT | Japan Society for the Promotion of Science (20H05922)
MEXT | Japan Society for the Promotion of Science (23K10432)
MEXT | Japan Society for the Promotion of Science (22K15793)
MEXT | Japan Society for the Promotion of Science (21K07508)
MEXT | Japan Society for the Promotion of Science (19H03587)
MEXT | Japan Society for the Promotion of Science (20K20603)
Takeda Science Foundation
Japan Research Foundation for Clinical Pharmacology
- License Information
-
More Information
Article History
Received: 14 April 2025
Revised: 10 January 2026
Accepted: 18 February 2026
First Online: 5 March 2026
Competing interests
: Takuya Takahashi is the inventor of a patent application for a novel compound that specifically binds to the AMPA receptor (WO 2017006931), including [ 11 C]K-2. Takuya Takahashi and Tetsu Arisawa are the founders and also stockholders of AMPAMETRY, Inc., which holds the exclusive license to use [ 11 C]K-2. No other potential conflicts of interest relevant to this article exist.
